Arcinova is a Contract Development and Manufacturing Organization operating from a 162,000ft 2 facility in the North of England. We deliver high quality end-to-end solutions by leveraging the knowledge and experience of multiple industry experts working side-by-side. Our wide range of services support clients across the drug development pathway to develop life changing medicines.
Back Bay Life Science Advisors provides integrated strategy and investment banking to global Biotech, Pharma and MedTech companies, academic centers of technology development, and life science investors.
We unify thriving life science ecosystems in the US, Europe, and beyond, and uncover the value of new technologies, medicines, and scientific approaches. Connect with our life science experts and read our latest industry white paper at bblsa.com
Evaluate provides trusted commercial intelligence for the pharmaceutical industry. Our EvaluatePharma® and EvaluatePharma Vision online services provide a seamless view of the past, present and future of the global pharmaceutical market in a single, standardised platform. For more information on how we give our clients the time and understanding to drive better decisions, visit www.evaluate.com.
Halloran Consulting Group makes life science companies better at what they do. We give you the direction and expertise needed to transform your company into a more efficient organization where quality is part of the culture, not an afterthought. We stick by your side when things get tough by helping to identify and fix problems within your organization. We’ve been there. We can find a solution.
inSeption’s insistence upon securing the “right” people to integrate into a true partnership alliance with its clients eliminates the vulnerability so often felt by operational leaders faced with evaluating traditional outsourcing options. inSeption’s core competency of identifying and securing the most experienced and proficient professionals builds the crucial foundation of a successful drug development program. Actively collaborating with its clients to custom design, hand select and assemble high-performing project teams empowers inSeption to tailor its services specifically to meet the needs of their programs. The inSeption model provides increased control, full transparency of project deliverables and timelines, and significant operational and cost efficiencies.
Description: Intelligencia applies predictive analytics to help pharma companies better understand and minimize the risk of drug development. Our core product uses machine learning to provide estimates of the probability of success (PTRS) of a particular drug, as well as recommendations for optimizing the clinical trial design in order to maximize that probability.
Parexel is focused on supporting the development of innovative new therapies to improve patient health. We do this through a suite of services that help life science and biopharmaceutical customers across the globe transform scientific discoveries into new treatments for patients. From clinical trials to regulatory and consulting services to commercial and market access, our therapeutic, technical and functional ability is underpinned by a deep conviction in what we do. For more information, visit our website and follow us on LinkedIn and Twitter. Parexel is a registered trademark of Parexel International Corporation. All other trademarks are the property of their respective owners.
SVA Bio-Ops partners with leaders of emerging life science companies to successfully plan and execute their transition from R&D to a commercial business. This means designing and building the business operations: all the functions, processes and systems necessary to generate revenue and address patient needs with a newly approved product. In the midst of the tremendous complexity and uncertainty of this transition, we help clients understand options, make decisions and manage their risk. We bring proven solutions and a network of providers we know and trust to help them be successful.
The Tufts Center for the Study of Drug Development at Tufts University School of Medicine is an internationally recognized academic research center committed to advancing biomedical innovation through authoritative research in the areas of pharmaceutical economics, regulation, law, policy, and science. Founded in 1976, Tufts CSDD provides data-driven analysis and strategic insight to help drug developers, regulators, and policy makers improve the efficiency and productivity of pharmaceutical R&D. Tufts CSDD also offers professional development courses, hosts workshops and public forums, and publishes the highly regarded Tufts CSDD Impact Report, focusing on critical drug development issues.